Ocular Therapeutix Inc (OCUL)

[Whalatane]

Scotiabank Initiates Coverage On Ocular Therapeutix with Sector Outperform Rating, Announces Price Target of $22

Kiwi

[Whalatane]

https://investors.ocutx.com/node/13236/pdf...trial enrolling ahead of schedule

Kiwi

[Whalatane]

As per the recent conference ...recruiting is going well and the speculation is that their trial will be fully enrolled ahead of schedule .
Eyelea ...the drug they will compete with ...is still increasing sales

Kiwi

[Whalatane]

Anybody out there ? Nice day to have a position in OCUL
Kiwi

[Whalatane]

OCUL. P2 data 4/5/24
REUTERS
10:03 AM ET 04/06/2024
April 6 (Reuters) - Ocular Therapeutix Inc (OCUL):
* OCULAR THERAPEUTIX™ ANNOUNCES POSITIVE PHASE 2 PAXTRAVA™ GLAUCOMA DATA AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY 2024 ANNUAL MEETING
* OCULAR THERAPEUTIX INC (OCUL) - GENERALLY WELL TOLERATED WITH NO IMPACT ON CORNEAL HEALTH OBSERVED
* OCULAR THERAPEUTIX INC (OCUL) - CLINICALLY MEANINGFUL MEAN IOP REDUCTION OF ABOUT 24-30% FROM BASELINE OBSERVED OVER SIX MONTHS Source text for Eikon: Further company coverage:

Kiwi

[Monksdream]

OCUL under $10

[Monksdream]

OCUL 10Q due March 11

[glenn1919]

OCUL....................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783

[trendzone]

Tard sells $6.00 call option at $0.15 at the close,apparently they were born yesterday.

[glenn1919]

OCUL..........................................https://stockcharts.com/h-sc/ui?s=OCUL&p=W&b=5&g=0&id=p86431144783

[trendzone]

Clueless fool sells $6.00 call option at $0.10 when they were just trading at $0.30,with the big rally going on in the stock today, what a total fool they are.

[cuggegrosse]

I chose OCUL to invest in because the market conditions should not effect the PPS(much),plus I can sell covered calls and make some monthly cash,besides they have products that are in demand !!!!

[cuggegrosse]

Yes I have noticed that

[Tzr250rg]

Ask is super thin wont take much to move. GLTUA

[cuggegrosse]

My eye doctor says Dextenza is a very good drug and he raccomends it !!!!!

[cuggegrosse]

DEXTENZA is doing very,very well,great revs expected in 2023

[cuggegrosse]

This company could go to $8.00 very eassy

[spotonge]

boys need to wake up

[biotechslayr]

Is anyone at all following OCUL into the end of the months binary? TKI data could be a game changer. Total TAM is ridiculous (look at REGN mcap!)

[oxnous]

OCUL --charting

[oxnous]

With the aging population, eye care is becoming an increasing concern. Dry eye, glaucoma, macular degeneration etc. will be expanding market sub sectors

[ClayTrader]

* * $OCUL Video Chart 04-29-2021 * *

Link to Video - click here to watch the technical chart video

[whytestocks]

Just In: $OCUL Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that its application for the creation of a Category I Current Procedural Ter...

In case you are interested OCUL - Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts

[whytestocks]

Breaking News: $OCUL Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

OTX-CSI demonstrates improvement in signs and symptoms of Dry Eye Disease Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the ey...

Got this from OCUL - Ocular Therapeutix(TM) Announces Topline Phase 1 Clinical Trial Results of OTX-CSI

[TheFinalCD]

OCUL 10.87 NEW HIGH OF DAY

[whytestocks]

Just In: $OCUL Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported preliminary, unaudited net product revenue for the third quarter ended Septe...

Find out more OCUL - Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter

[now invest]

Thus far OCUL is trading nicely!!

[ClayTrader]

* * $OCUL Video Chart 05-22-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $OCUL Video Chart 03-04-2020 * *

Link to Video - click here to watch the technical chart video

[edwardport]

near term 10% projected increase in market price

closed on 2/7/20 @ $5.21

[ClayTrader]

* * $OCUL Video Chart 02-07-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $OCUL Video Chart 01-03-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $OCUL Video Chart 11-29-2019 * *

Link to Video - click here to watch the technical chart video

[TFMG]

OCUL - POSSIBLE 25% TREND MOVE ON THE DAILY

Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

SHORT INTEREST
8.24M 07/15/19

P/E Current
-2.78

P/E Ratio (with extraordinary items)
-2.92

Average Recommendation: OVERWEIGHT

Average Target Price: 9.67

[tste9]

Great news! BUT, hoped for more volume price etc. wow
GLA

[ClayTrader]

* * $OCUL Video Chart 07-26-2019 * *

Link to Video - click here to watch the technical chart video

[whytestocks]

News: $OCUL Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a ...

Got this from Ocular Therapeutix(TM) Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services

[smallbio]

Is DEXTENZA currently only targeting medicare patients, as there is no private insurance company will reimburse the cost?

[tste9]

What is up with this little piggy, lately! #&*#@*

[tste9]

Great news thanks for post. Do you know of any web site that posts OCUL sales per week. Thank you. GL

[whytestocks]

News: $OCUL Ocular Therapeutix(TM) Announces Commercial Launch of DEXTENZA® (dexamethasone intracanalicular insert) 0.4 mg for Ophthalmic Use in the United States

Pass-through payment status and C-code from the Centers for Medicare and Medicaid Services (CMS) now active Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and ...

In case you are interested https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-commercial-launch-of-dextenza-x-8439742.html

[swingingRichard]

Shorted 10,000 shares. Looking good.

[tste9]

Shorts ease out as usual. criminal how shorts manipulate SP then just slither out unharmed. GLA

[tste9]

YEA BABY!

[ClayTrader]

* * $OCUL Video Chart 06-21-2019 * *

Link to Video - click here to watch the technical chart video

[whytestocks]

News: $OCUL Ocular Therapeutix(TM) Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (0.4 Dexamethasone Intracanalicular Insert for Ophthalmic Use) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

DEXTENZA ® Now Approved for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...

Find out more https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-fda-approval-of-supplemental-new-drug-application-snda-for-dextenza-xae-0-4-dexamethasone-intracanalicular-insert-for-ophthalmic-use-for-the-treatment-of-ocular-inflammation-following-ophthalmic-surgery-8394606.html

[ClayTrader]

* * $OCUL Video Chart 06-11-2019 * *

Link to Video - click here to watch the technical chart video

[Tzr250rg]

low volume today

[whytestocks]

News: $OCUL Ocular Therapeutix(TM) Announces Receipt of C-Code and Pass-Through Payment Status for DEXTENZA®

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved t...

Got this from https://marketwirenews.com/news-releases/ocular-therapeutix-tm-announces-receipt-of-c-code-and-pass-through-payment-status-for-dextenza-xae--8261962.html

[ClayTrader]

* * $OCUL Video Chart 05-21-2019 * *

Link to Video - click here to watch the technical chart video